Cite
Moerman A, Vernelen K, China B, et al. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagn Microbiol Infect Dis. 2021;102(2):115561doi: 10.1016/j.diagmicrobio.2021.115561.
Moerman, A., Vernelen, K., China, B., Capron, A., Bossche, D. V. D., Mariën, J., Ariën, K. K., Van Acker, J., Delforge, M. L., Reynders, M., Boel, A., Depypere, M., Van Gasse, N., Vijgen, S., Brauner, J., Dujardin, B., & Padalko, E. (2022). Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagnostic microbiology and infectious disease, 102(2), 115561. https://doi.org/10.1016/j.diagmicrobio.2021.115561
Moerman, Alena, et al. "Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme." Diagnostic microbiology and infectious disease vol. 102,2 (2022): 115561. doi: https://doi.org/10.1016/j.diagmicrobio.2021.115561
Moerman A, Vernelen K, China B, Capron A, Bossche DVD, Mariën J, Ariën KK, Van Acker J, Delforge ML, Reynders M, Boel A, Depypere M, Van Gasse N, Vijgen S, Brauner J, Dujardin B, Padalko E. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagn Microbiol Infect Dis. 2022 Feb;102(2):115561. doi: 10.1016/j.diagmicrobio.2021.115561. Epub 2021 Oct 11. PMID: 34773801; PMCID: PMC8503966.
Copy
Download .nbib